Sanegene Bio Revenue and Competitors
Estimated Revenue & Valuation
- Sanegene Bio's estimated annual revenue is currently $4.3M per year.
- Sanegene Bio's estimated revenue per employee is $188,696
- Sanegene Bio's total funding is $130M.
Employee Data
- Sanegene Bio has 23 Employees.
- Sanegene Bio grew their employee count by 15% last year.
Sanegene Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Technology Officer & Head, US Operations | Reveal Email/Phone |
2 | Head CMC | Reveal Email/Phone |
3 | Director PD and Manufacturing | Reveal Email/Phone |
4 | Director | Reveal Email/Phone |
5 | Sr. Principal Scientist | Reveal Email/Phone |
6 | Senior Scientist I | Reveal Email/Phone |
Sanegene Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Sanegene Bio?
SanegeneBio is an emerging RNAi-based company developing innovative RNA interference (RNAi) therapeutics driven by the cutting-edge delivery technology. Founded in 2021, SanegeneBio was propelled by a team of industry-leading experts and has operations in both the US and China. Since its inception, SanegeneBio has successfully established proprietary chemical modification platform, hepatic and extrahepatic delivery platforms, enabling tissue-specific delivery of a wide range of RNA therapeutics to efficiently knock down disease-causing genes. Our fast-growing RNAi portfolio covers a broad range of therapeutic areas including cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases. Among them, our first RNAi drug has entered the clinical stage, and several pipelines are in progress simultaneously. SanegeneBio is committed to creating transformational RNAi medicines through striving for scientific innovation to address unmet medical needs worldwide and change the lives of patients and families.
keywords:N/A
$130M
Total Funding
23
Number of Employees
$4.3M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Woburn
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.3M | 23 | 10% | N/A |
#2 | $3.2M | 23 | 10% | N/A |
#3 | $4.7M | 25 | -11% | N/A |
#4 | $4.9M | 26 | 0% | N/A |
#5 | $4.9M | 26 | -24% | N/A |